Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Sinbaglustat by Idorsia Pharmaceutical for Tay-Sachs Disease: Likelihood of Approval
Sinbaglustat is under clinical development by Idorsia Pharmaceutical and currently in Phase I for Tay-Sachs Disease. According to GlobalData, Phase...